Candida auris, a recently recognized, often multidrug-resistant yeast, has become a
significant fungal pathogen due to its ability to cause invasive infections and outbreaks in …

Abstract Purpose of Review Emergent fungal pathogen C. auris is spreading in hospitals
throughout the world and mortality rates for patients with invasive disease approach 60 …

Introduction Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise
in cases of colonization and infection has been registered in intensive care units (ICUs) …

Candida auris is an emerging MDR pathogen raising major concerns worldwide. In Italy, it
was first and only identified in July 2019 in our hospital (San Martino Hospital, Genoa) …

Candida auris is an emerging, multidrug resistant fungal pathogen that causes considerable
morbidity and mortality. First identified in Japan in 2009, it has since been reported in more …

Candida auris has unprecedently emerged as a multidrug resistant fungal pathogen,
considered a serious global threat due to its potential to cause nosocomial outbreaks and …

Abstract Purpose of Review Candida auris, a recently recognized yeast pathogen, has
become a major public health threat due to the problems associated with its accurate …

Candida auris recently emerged as an urgent public health threat, causing outbreaks of
invasive infections in healthcare settings throughout the world. This fungal pathogen persists …

Background Candida auris is an emerging, potentially multidrug‐resistant pathogen that
exhibits clade‐specific resistance to fluconazole and also develops resistance to …

Candida auris is an emerging fungal pathogen with unusual evolutionary history—there are
multiple distinct phylogeographic clades showing a near simultaneous transition from a …